Stock News

New York City, NY – September 16, 2024 Bronstein, Gewirtz & Grossman, LLC Investigates Potential Claims Against Adobe Inc. Bronstein, Gewirtz & Grossman, LLC, a leading law firm based in New York City, is currently investigating potential claims on behalf of purchasers of Adobe Inc. (“Adobe” or “the Company”) (NASDAQ:ADBE). Investors who have purchased Adobe…

Politan Capital Management Issues Open Letter to Masimo Corporation Shareholders New York, NY – Politan Capital Management, a major shareholder of Masimo Corporation, has released a letter to shareholders urging support for its nominees at the upcoming Annual Meeting of Stockholders. Dear Fellow Masimo Shareholders, Politan Capital Management, together with its affiliates, has recently announced…

Vince Holding Corp. (NYSE:VNCE) Q2 2024 Earnings Conference Call September 16, 2024 4:30 PM ET Welcome to the Vince Second Quarter 2024 Earnings Conference Call. We are pleased to have you join us today as we discuss our company’s recent performance and future outlook. Leading the call today, we have Akiko Okuma, our Investor Relations…

Micromem Technologies Inc. Announces Non-brokered Private Placement Toronto, Ontario and New York, New York— Micromem Technologies Inc. (CSE: MRM) (OTCQB: MMTIF) (“Micromem” or the “Company”) announces the intention to proceed with a non-brokered private placement (the “Private Placement”) by issuing common share units comprised of one share and one warrant, each share priced at $0.03…

American Potash Corp. Successfully Closes Private Placement Vancouver, BC / ACCESSWIRE / September 16, 2024 American Potash Corp. (“American Potash”or the”Company”) (CSE:KCL)(OTC PINK:APCOF)(FRA:2P3) has announced the successful closing of the second and final tranche of its non-brokered private placement, raising a total of $1,023,000. The Company issued 4,300,000 units at a price of $0.05 per…

Pharma-Bio Serv Announces Decrease in Revenues for 2024 Overview Pharma-Bio Serv, Inc. recently announced a decrease in revenues for the three and nine months ended July 31, 2024. The company reported revenues of approximately $2.4 million and $7.2 million for the respective periods, marking a significant decrease compared to the same periods last year. Financial…

Exciting Developments in Breast Cancer Treatment Relay Therapeutics, Inc. recently shared positive interim data from its phase 1 ReDiscover study, which focused on the use of RLY-2608 in combination with fulvestrant to treat PI3Ka-mutated HR+/HER2- locally advanced or metastatic breast cancer patients. This news marks a significant step forward in the fight against this deadly…

Rosen Law Firm Announces Class Action Lawsuit Against Agenus Inc. New York, Sept. 16, 2024 (GLOBE NEWSWIRE) Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Agenus Inc. (NASDAQ: AGEN) between January 23, 2023 and July 17, 2024, both dates…